Excel Add-In GURUF
API
My Portfolios
Create New Portfolio
Portfolio Contest
My Gurus
Personalize
My Gurus
Bookmark
Print
This page was added to your CFO & COO, Lab Operations of Medpace Holdings Inc (30-Year Financial, Insider Trades) Jesse J Geiger (insider trades) sold 4,200 shares of MEDP on 12/14/2020 at an average price of $142 a share. The total sale was $596,400.
Medpace Holdings Inc is a clinical contract research organisation. It is engaged in providing scientifically-driven clinical research-based drug and medical device development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings Inc has a market cap of $5.2 billion; its shares were traded at around $145.320000 with a P/E ratio of 44.44 and P/S ratio of 6.14.
CEO Recent Trades:
- President & CEO, 10% Owner August J. Troendle sold 14,000 shares of MEDP stock on 12/01/2020 at the average price of $130.86. The price of the stock has increased by 11.05% since.
- Warning! GuruFocus has detected 5 Warning Signs with MEDP. Click here to check it out.
- MEDP 30-Year Financial Data
- The intrinsic value of MEDP
- Peter Lynch Chart of MEDP
CFO Recent Trades:
- CFO & COO, Lab Operations Jesse J Geiger sold 4,200 shares of MEDP stock on 12/14/2020 at the average price of $142. The price of the stock has increased by 2.34% since.
Directors and Officers Recent Trades:
- General Counsel & Corp. Secy. Stephen P Ewald sold 10,000 shares of MEDP stock on 12/10/2020 at the average price of $140.07. The price of the stock has increased by 3.75% since.
- 10% Owner Investors, Llc Medpace sold 14,000 shares of MEDP stock on 12/01/2020 at the average price of $130.86. The price of the stock has increased by 11.05% since.
For the complete insider trading history of MEDP, click here
.- CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
- Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
- Double Buys:: Companies that both Gurus and Insiders are buying
- Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.
Subscribe
via Email
Subscribe RSS
